These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 15800116

  • 1. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.
    Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz HU, Meri S, Rose NR, Salant DJ, Sethi S, Smith RJ, Smoyer W, Tully HF, Tully SP, Walker P, Welsh M, Würzner R, Zipfel PF.
    J Am Soc Nephrol; 2005 May; 16(5):1392-403. PubMed ID: 15800116
    [Abstract] [Full Text] [Related]

  • 2. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C, Fremeaux-Bacchi V.
    Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
    [Abstract] [Full Text] [Related]

  • 3. Management of membranoproliferative glomerulonephritis type II with plasmapheresis.
    Kurtz KA, Schlueter AJ.
    J Clin Apher; 2002 Feb; 17(3):135-7. PubMed ID: 12378549
    [Abstract] [Full Text] [Related]

  • 4. Dense deposit disease in a child with febrile sore throat.
    Conti G, De Vivo D, Vitale A, Fede C, Santoro D.
    Saudi J Kidney Dis Transpl; 2017 Feb; 28(4):925-928. PubMed ID: 28748900
    [Abstract] [Full Text] [Related]

  • 5. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM, Dimitrjević JZ, Nikolić VN, Ognjanović MV, Rodić BD, Slavković BV.
    Srp Arh Celok Lek; 1999 Feb; 127(5-6):163-71. PubMed ID: 10500423
    [Abstract] [Full Text] [Related]

  • 6. Membranoprolferative glomerulonephritis - mechanisms and treatment.
    Appel GB.
    Contrib Nephrol; 2013 Feb; 181():163-74. PubMed ID: 23689578
    [Abstract] [Full Text] [Related]

  • 7. Heterogeneous pattern of renal disease associated with homozygous factor H deficiency.
    Servais A, Noël LH, Dragon-Durey MA, Gübler MC, Rémy P, Buob D, Cordonnier C, Makdassi R, Jaber W, Boulanger E, Lesavre P, Frémeaux-Bacchi V.
    Hum Pathol; 2011 Sep; 42(9):1305-11. PubMed ID: 21396679
    [Abstract] [Full Text] [Related]

  • 8. Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children.
    Davis AE, Schneeberger EE, Grupe WE, McCluskey RT.
    Clin Nephrol; 1978 May; 9(5):184-93. PubMed ID: 657595
    [Abstract] [Full Text] [Related]

  • 9. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification.
    Sethi S, Fervenza FC.
    Semin Nephrol; 2011 Jul; 31(4):341-8. PubMed ID: 21839367
    [Abstract] [Full Text] [Related]

  • 10. Dense deposit disease: new insights.
    Walker PD.
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):204-12. PubMed ID: 17420663
    [Abstract] [Full Text] [Related]

  • 11. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP, Pertosa G, Stanziale P, Vox E, Pecoraro C, Andreucci VE.
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [Abstract] [Full Text] [Related]

  • 12. Anti-factor B autoantibody in dense deposit disease.
    Strobel S, Zimmering M, Papp K, Prechl J, Józsi M.
    Mol Immunol; 2010 Apr; 47(7-8):1476-83. PubMed ID: 20193965
    [Abstract] [Full Text] [Related]

  • 13. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Józsi M.
    Mol Immunol; 2009 Sep; 46(14):2801-7. PubMed ID: 19640589
    [Abstract] [Full Text] [Related]

  • 14. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
    West CD, McAdams AJ.
    Am J Kidney Dis; 1998 Jul; 32(1):56-63. PubMed ID: 9669425
    [Abstract] [Full Text] [Related]

  • 15. Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation.
    Frémeaux-Bacchi V, Weiss L, Brun P, Kazatchkine MD.
    Nephrol Dial Transplant; 1994 Jul; 9(7):811-4. PubMed ID: 7970124
    [Abstract] [Full Text] [Related]

  • 16. Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).
    Jansen JH, Høgåsen K, Mollnes TE.
    Am J Pathol; 1993 Nov; 143(5):1356-65. PubMed ID: 8238252
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of membranoproliferative glomerulonephritis type II and pregnancy: a case report.
    Inaba S, Tanizawa T, Igarashi T, Higuchi A, Satou H, Mase D, Asada R, Suzuki Y, Okada T.
    Clin Nephrol; 1989 Jul; 32(1):10-3. PubMed ID: 2758699
    [Abstract] [Full Text] [Related]

  • 18. [Ocular impairment during type II membranoproliferative glomerulonephritis].
    Lahbil D, Rais L, Hamdani M, El Kettani A, Laouissi N, Zaghloul K, Amraoui A.
    J Fr Ophtalmol; 2002 Nov; 25(9):949-54. PubMed ID: 12515943
    [Abstract] [Full Text] [Related]

  • 19. The role of complement in C3 glomerulopathy.
    Zipfel PF, Skerka C, Chen Q, Wiech T, Goodship T, Johnson S, Fremeaux-Bacchi V, Nester C, de Córdoba SR, Noris M, Pickering M, Smith R.
    Mol Immunol; 2015 Sep; 67(1):21-30. PubMed ID: 25929733
    [Abstract] [Full Text] [Related]

  • 20. [Clinicopathological survey of persistent hypocomplementemic glomerulonephritis in children; correlation of DPGN and MPGN type I].
    Hattori S, Hiramatsu M, Ushijima T, Karashima S, Furuse A, Matsuda I, Takebayashi S.
    Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):773-81. PubMed ID: 1479716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.